MANORG NSI Week ended 07 Aug 2026

Weekly Investor Report

Mangalam Organics Limited · Basic Materials · Specialty Chemicals

Open interactive chart View report data
Latest close 457.9 INR
-6.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is -3.8% below the Trend Line and sits at 36.1% of its 52-week range. The latest completed week returned -6.3%, after a -14.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100.

Setup score 34 out of 100
Latest Close 457.9 INR 7 Aug 2026
1W Return -6.3% latest completed week
4W Return -14.4% short-term follow-through
12W Return -20.3% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • The trend backdrop is active with a 11-week active streak.
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 42.99% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.3% Latest completed week; four-week move -14.4%. Indicator stack 61/36 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.99% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 15 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -3.8% below the Trend Line and sits at 36.1% of its 52-week range. The latest completed week returned -6.3%, after a -14.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6312-week average 0.56

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.63Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -14.4% over four weeks, -20.3% over 12 weeks, and 1.0% over one year. The current trend has remained active for 11 consecutive weeks.

Performance by holding period

1W-6.3%
4W-14.4%
12W-20.3%
26W5.4%
52W1.0%
Active trend streak11 weeks
Active weeks in one year22
Trend breadth42.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.17Latest activity-pressure read.
Pressure change-137.3%Four-week change in activity pressure.
Leadership-6.73Latest relative-leadership reading.
RS change-159.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength79/100Blend of value, momentum, and quality. Underlying universe rank 22; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality21/100Profitability and accounting quality. Underlying universe rank 80; rank 1 is best.
Momentum70/100Medium-term price momentum. Underlying universe rank 31; rank 1 is best.
Growth90/100Revenue and earnings growth. Underlying universe rank 11; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework69/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
15.2x
Price divided by trailing earnings.
Price / sales
0.6x
Market value relative to trailing revenue.
EV / EBITDA
8.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-8.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
47.3%
Gross profit retained from each unit of revenue.
Operating margin
9.7%
Operating profit retained from revenue.
Free-cash-flow margin
-10.1%
Free cash flow generated from revenue.
Return on invested capital
6.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
17.5%
Latest one-year revenue growth.
EPS growth
104.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 15 relevant articles.

5 positive · 8 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.2%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+31.5%Week of 8 May.
Worst week-18.7%Week of 5 Jun.
Latest week-6.3%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks0
Modest losses6
Sharp losses9
Recent vol8.3%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew7.9% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape40/100

Trend, activity pressure, participation, and risk combine to a 40/100 tape read.

 Indicator analysis79/100

Latest 12-week confirmation: trend 11/12, activity pressure 11/12, relative leadership 11/12.

Activity pressure 0.63; No reversal markers Next-Week ExpectancyNegative 42.99%

Next-week expectancy is negative with a 42.99% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors61/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 27; Buyback Yield rank 44; Small Cap Core rank 35 SVQF69/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 482.5 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 15 relevant articles.

Mangalam Organics consolidated profit falls 41% in Q1FY27 despite revenue growth Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026457.9 INR-6.3%476.0 INR451.0 INR-0.17-6.7341.5KOn
31 Jul 2026488.5 INR-6.7%477.5 INR450.9 INR0.060.2736.0KOn
24 Jul 2026523.6 INR-6.1%477.3 INR450.7 INR0.2310.3428.4KOn
17 Jul 2026557.6 INR4.2%475.9 INR450.2 INR0.3815.0727.4KOn
10 Jul 2026535.0 INR2.6%473.1 INR449.5 INR0.4511.3211.2KOn
3 Jul 2026521.6 INR-5.5%471.4 INR448.8 INR0.438.283.6KOn
26 Jun 2026552.2 INR-2.0%470.3 INR448.1 INR0.4815.590On
19 Jun 2026563.5 INR19.8%468.4 INR447.3 INR0.6218.245.5KOn
12 Jun 2026470.5 INR0.2%464.8 INR446.4 INR0.750.385.4KOn
5 Jun 2026469.5 INR-18.7%467.1 INR446.2 INR1.010.9961.1KOn
29 May 2026577.4 INR-0.4%467.4 INR445.8 INR1.2822.9426.3KOn
22 May 2026579.8 INR0.9%465.2 INR444.8 INR1.2522.7217.7KOff
15 May 2026574.8 INR-4.3%463.1 INR444.1 INR1.1622.2256.3KOff
8 May 2026600.3 INR31.5%460.5 INR443.5 INR1.1325.02317.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context